Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,423,002
+$13,070 QoQ
Shares Held
104,792
-2.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#132
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $338,415,690 across 14 Drug Manufacturers - General names. NVS ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
336,570 | $85,478,682 | |
| 2 | LLY |
ELI LILLY & Co
|
59,006 | $70,773,572 | |
| 3 | ABBV |
AbbVie Inc.
|
190,827 | $48,019,706 | |
| 4 | MRK |
Merck & Co., Inc.
|
271,475 | $34,884,537 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
417,663 | $24,065,742 | |
| 6 | AMGN |
Amgen Inc
|
47,883 | $17,339,391 | |
| 7 | NVS |
Novartis AG
This page
|
104,792 | $16,423,002 | |
| 8 | PFE |
Pfizer Inc
|
634,638 | $15,282,083 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,423,002 | 104,792 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,409,932 | 107,430 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,728,927 | 106,832 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,897,625 | 108,372 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $12,700,241 | 104,952 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $12,690,102 | 113,833 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,579,548 | 36,785 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,987,432 | 78,138 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,418,771 | 69,686 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,830,787 | 60,279 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,819,103 | 57,632 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,679,917 | 55,762 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,355,798 | 53,075 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,863,828 | 20,259 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,822,746 | 20,092 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,789,275 | 23,540 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,999,895 | 23,659 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,164,792 | 24,670 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,095,606 | 23,958 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,123,172 | 25,962 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,868,960 | 20,484 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,376,771 | 27,805 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,423,073 | 25,660 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,874,248 | 21,553 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,236,428 | 25,606 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $673,946 | 8,174 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||